Journal
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES
Volume 19, Issue 1, Pages 3-9Publisher
ELSEVIER
DOI: 10.1016/j.jstrokecerebrovasdis.2009.09.005
Keywords
Adult stem cell; injury; proliferation; intranasal; neurotrophic factor; PEGylation
Categories
Ask authors/readers for more resources
We previously demonstrated that infusion of transforming growth factor (TGF)-alpha after chronic middle cerebral artery occlusion (MCAO) stimulates stem and progenitor cell proliferation, migration, and neuronal differentiation associated with the amelioration of neurologic impairment. But the use of TGF-alpha in humans is impeded by impracticality of intracranial infusion and the inability of intravenous TGF-alpha to cross the blood-brain barrier. Here we investigated whether intranasal delivery of PEGylated TGF-alpha (PEG-TGF-alpha) is a viable alternative. We found that intranasal PEG-TGF-alpha can also induce the proliferation of neural progenitors and their migration to the damaged striatum, and that this is associated with significant behavioral improvement in the MCAO model. This nonsurgical approach represents a potential therapeutic strategy for human patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available